What may have seemed like an out-of-the-blue question to the casual observer was no surprise to those who represent individuals and entities in the health care and life sciences industries: U.S. Attorney General (AG) nominee Pam Bondi was asked to share her thoughts on the constitutionality of the False Claims Act (FCA) and its qui tam provisions during her January 15, 2025, confirmation hearings.
Senator Chuck Grassley (R-IA) prefaced his questioning by noting that the FCA is “central to fighting government waste and fraud.” And since 1986—when Grassley authored amendments that modernized and strengthened the Civil War-era statute—he has been a fierce defender. Since the 1986 amendments, the FCA has brought in $78 billion for the federal government, with more than $2.9 billion recovered in fiscal year (FY) 2024.
“Most of that is due to patriotic whistleblowers who found the fraud and brought the cases forward at their own risk,” Grassley said.
Blog Editors
Recent Updates
- A Step Closer to the Proposed End of the Self-Affirmed GRAS Pathway
- Imports and the DOJ’s Trade Fraud Task Force: Considerations for the Health Care and Life Sciences Industries
- Federal Appellate Court Upholds Mississippi 340B Contract Pharmacy Protections
- DOJ False Claims Act Priorities: Cybersecurity Is Still on the Radar
- DOJ Launches Cross-Agency Trade Fraud Task Force: What Importers and Businesses Need to Know